PUMA: A puzzle piece in chloroquine's antimelanoma activity

Journal of Investigative Dermatology

Volumn 133, Issue 9, 2013, Pages 2133-2135

  Amaravadi, Ravi K ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; PUMA PROTEIN;

ANTINEOPLASTIC ACTIVITY; AUTOPHAGY; CELL DEATH; DRUG MECHANISM; HUMAN; MELANOMA CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVIEW;

EID: 84884363796     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2013.135     Document Type: Note

References (14)

1. Amaravadi RK, Lippincott-Schwartz J, Yin XM et al. (2011) Principles and current strategies for targeting autophagy for cancer treatment. Clin Cancer Res 17:654-66
2. Bray K, Mathew R, Lau A et al. (2012) Autophagy suppresses RIP kinase-dependent necrosis enabling survival to mTOR inhibition. PLoS One 7:e41831
3. Carter AE, Eban R (1974) Prevention of postoperative deep venous thrombosis in legs by orally administered hydroxychloroquine sulphate. Br Med J 3:94-5
4. Graves PR, Kwiek JJ, Fadden P et al. (2002) Discovery of novel targets of quinoline drugs in the human purine binding proteome. Mol Pharmacol 62:1364-72
5. Jensen M, Mehlhorn H (2009) Seventy-five years of resochin in the fight against malaria. Parasitol Res 105:609-27
6. Katz SJ, Russell AS (2011) Re-evaluation of antimalarials in treating rheumatic diseases: Re-Appreciation and insights into new mechanisms of action. Curr Opin Rheumatol 23:278-81
7. Khoury H, Trinkaus K, Zhang MJ et al. (2003) Hydroxychloroquine for the prevention of acute graft-versus-host disease after unrelated donor transplantation. Biol Blood Marrow Transplant 9:714-21
8. Kim J, Yip ML, Shen X et al. (2012) Identification of anti-malarial compounds as novel antagonists to chemokine receptor CXCR4 in pancreatic cancer cells. PLoS One 7:e31004
9. Lakhter AJ, Sahu RP, Sun Y et al. (2013) Chloroquine promotes apoptosis in melanoma cells by inhibiting BH3 domain mediated PUMA degradation. J Invest Dermatol 133:2247-54
10. Lazova R, Camp RL, Klump V et al. (2012) Punctate LC3B expression is a common feature of solid tumors and associated with proliferation, metastasis, and poor outcome. Clin Cancer Res 18:370-9
11. McAfee Q, Zhang Z, Samanta A et al. (2012) Autophagy inhibitor Lys05 has single-Agent antitumor activity and reproduces the phenotype of a genetic autophagy deficiency. Proc Natl Acad Sci USA 109:8253-8
12. Munster T, Gibbs JP, Shen D et al. (2002) Hydroxychloroquine concentration-response relationships in patients with rheumatoid arthritis. Arthritis Rheum 46:1460-9
13. Paton NI, Goodall RL, Dunn DT et al. (2012) Effects of hydroxychloroquine on immune activation and disease progression among HIV-infected patients not receiving antiretroviral therapy: A randomized controlled trial. JAMA 308:353-61
14. Taha MO, Bustanji Y, Al-Ghussein MA et al. (2008) Pharmacophore modeling, quantitative structure-Activity relationship analysis, and in silico screening reveal potent glycogen synthase kinase-3beta inhibitory activities for cimetidine, hydroxychloroquine, and gemifloxacin. J Med Chem 51:2062-77